Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Q3 Revenues Rise 8 Percent as Profit Surges 43 Percent

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said third-quarter revenues increased 8 percent as R&D spending rose 8 percent and profit increased 43 percent.
Total receipts for the three months ended Sept. 30 increased to $305 million from $283 million year over year.
Revenue from the company’s Life Science division was up 4 percent to $137 million from $132 million while receipts from the Clinical Diagnostics segment jumped 11 percent to $164 million from $148 million year over year.
Bio-Rad said increased sales in Life Science came from first orders of its new Protein Array Interaction System, and the growth in its Clinical Diagnostics was “across all product lines.”
R&D spending increased to $31 million from $29 million year over year.
The company said third-quarter profit increased to $23.1 million from $16.2 million in the year-ago period.
Bio-Rad said it had around $481.5 million in cash, cash equivalents, and short-term investments as of Sept. 30.
Yesterday, GenomeWeb News reported that Bio-Rad’s impending acquisition of Ciphergen’s proteomics tool business has been delayed. In a statement, Bio-Rad said the acquisition "is in the process of being completed."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.